SCHEMBL2411522

SCHEMBL2411522

CC(C)(C)NC(=O)OO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2757922 0.79
SCHEMBL15097744 0.76 POLB (0.37)
SCHEMBL1289839 0.74
SCHEMBL6676461 0.74
SCHEMBL22778278 0.74
SCHEMBL132657 0.74 DGAT1 (0.42)
SCHEMBL6792199 0.74
SCHEMBL28978930 0.74
SCHEMBL7815595 0.72 EPHX1 (0.42)
Ammonia Solution, Strong SCHEMBL9998482 0.72 DGAT1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11160783-B2 Multikinase inhibitors for use in the treatment of cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-11-02 US disclosed
US-20180353468-A1 MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-12-13 US disclosed
EP-2182941-B1 MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER EISAI R&D MAN CO LTD (JP) 2018-02-28 EP disclosed
CN-104662082-B High melt strength polypropylene of improved quality 北欧化工公司 2017-04-12 CN disclosed
CN-104204115-B The extrusion coated polymeric layer that coefficient of friction reduces 北欧化工公司 2016-11-23 CN disclosed
EP-2794603-B1 [1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPODIESTERASE INHIBITORS LEO PHARMA AS (DK) 2016-06-15 EP disclosed
US-9181248-B2 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors LEO PHARMA A/S (DK) 2015-11-10 US disclosed
US-20150182496-A1 MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-07-02 US disclosed
US-20150105420-A1 [1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2015-04-16 US disclosed
US-8940761-B2 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors LEO PHARMA A/S (DK) 2015-01-27 US disclosed
EP-2181104-B1 ZEARALENONE MACROLIDE DERIVATIVES AND USES OF THE SAME EISAI R&D MAN CO LTD (JP) 2011-09-07 EP disclosed
US-7858388-B2 MS based peptide and protein sequencing via reactions of lysine residues with peroxycarbonate compounds VANDERBILT UNIVERSITY (US) 2010-12-28 US disclosed
EP-2182941-A2 MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER Eisai R&D Management Co., Ltd. (JP) 2010-05-12 EP disclosed
EP-2181104-A1 ZEARALENONE MACROLIDE DERIVATIVES AND USES OF THE SAME Eisai R&D Management Co., Ltd. (JP) 2010-05-05 EP disclosed
US-20090082313-A1 Multikinase Inhibitors for Use in the Treatment of Cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-03-26 US disclosed
US-20090048333-A1 Zearalenone Macrolide Derivatives and Uses of the Same EISAI CO., LTD. (JP) 2009-02-19 US disclosed
WO-2009015368-A2 MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-29 WO disclosed
WO-2009015363-A1 ZEARALENONE MACROLIDE DERIVATIVES AND USES OF THE SAME EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-29 WO disclosed
US-20070249056-A1 Peptide and Protein Fragmentation by Lysine Residue Originated Reactions VANDERBILT UNIVERSITY 2007-10-25 US disclosed
WO-2005037857-A2 METHOD OF PROTEIN ANALYSIS BY MALDI USING PROTEIN FRAGMENTATION WITH PEROXYCARBONATES VANDERBILT UNIVERSITY (US) 2005-04-28 WO disclosed